• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

霍奇金氏淋巴肉芽肿的卡介苗接种

BCG vaccination in Hodgkin's lymphogranuloma.

作者信息

Kolár V, Opat P, Hrdlicková N

出版信息

Neoplasma. 1979;26(1):13-6.

PMID:431752
Abstract

Results of active non-specific immunotherapy in 25 patients suffering from Hodgkin's disease are given. All of them, being at the stage of a complete remission (residual disease) were divided into two groups according to the clinical stage: group 1 at the stage I and II and group 2 at the stage III and IV. To each vaccinated patient a non-vaccinated control, being at the same stage of disease and of approximately the same age, was selected by applying the method A--B. Results as to the survival time and the remission duration were in both vaccinated groups significantly longer although less significant in patients with an advanced stage of the disease. The present report is to be considered preliminary and the research work is carried on.

摘要

给出了25例霍奇金病患者进行主动非特异性免疫治疗的结果。所有患者均处于完全缓解期(残留病灶),根据临床分期分为两组:第1组为Ⅰ期和Ⅱ期,第2组为Ⅲ期和Ⅳ期。采用A - B法为每例接种疫苗的患者选择了一名处于相同疾病阶段且年龄相近的未接种疫苗的对照。在两个接种疫苗的组中,患者的生存时间和缓解持续时间均显著延长,尽管在疾病晚期患者中不太显著。本报告应视为初步报告,研究工作仍在进行中。

相似文献

1
BCG vaccination in Hodgkin's lymphogranuloma.霍奇金氏淋巴肉芽肿的卡介苗接种
Neoplasma. 1979;26(1):13-6.
2
[BCG immunotherapy in malignant lymphogranuloma].[卡介苗免疫疗法治疗恶性淋巴肉芽肿]
Sb Lek. 1991 May;93(3-4):84-94.
3
Preliminary evaluation of immunotherapy in patients with Hodgkin's disease.
Arch Immunol Ther Exp (Warsz). 1981;29(6):739-55.
4
[Therapeutic results in lymphogranulomatosis and their relationship to immunological reactivity].[淋巴肉芽肿的治疗结果及其与免疫反应性的关系]
Vopr Onkol. 1981;27(4):22-6.
5
[Treatment of Hodgkin's disease: review of 90 cases].
Arch Sci Med (Torino). 1979 Apr-Jun;136(2):295-302.
6
Bacille Calmette-Guérin as maintenance therapy for non-Hodgkin's lymphoma.卡介苗作为非霍奇金淋巴瘤的维持治疗
Can Med Assoc J. 1983 Sep 1;129(5):439-42.
7
[BCG-non specific immunotherapy of Hodgkin's disease. Preliminary results from a controlled investigation].[卡介苗对霍奇金病的非特异性免疫治疗。一项对照研究的初步结果]
Acta Haematol. 1974;52(4):214-9. doi: 10.1159/000208243.
8
MER immunotherapy and combination chemotherapy for advanced, recurrent Hodgkin's disease. Cancer and Leukemia Group B study.美罗华免疫疗法与联合化疗治疗晚期复发性霍奇金淋巴瘤。癌症与白血病B组研究。
Cancer Clin Trials. 1981;4(2):99-105.
9
Sensitization potential and reactogenicity of BCG with and without various doses of killed Mycobacterium leprae.卡介苗(BCG)与不同剂量灭活麻风分枝杆菌联合或不联合使用时的致敏潜力和反应原性。
Int J Lepr Other Mycobact Dis. 1992 Sep;60(3):340-52.
10
[A retrospective analysis of the treatment results in Hodgkin's disease in a radiotherapy clinic].[某放疗诊所霍奇金病治疗结果的回顾性分析]
Strahlenther Onkol. 1994 Sep;170(9):516-23.